Radiotherapy helps halve prostate cancer deaths: Lancet

Posted on Nov 03, 2011

Radiotherapy should "urgently" be added to the standard treatment for men with high risk prostate cancer, a charity has said, after a study showed it could almost halve deaths from the disease.

The study by British and Canadian researchers, published today (THUR) in The Lancet and part funded by the UK Medical Research Council, found adding radiotherapy to standard hormonal treatment cut deaths from locally advanced prostate cancer by 43 per cent over six years.

Locally advanced prostate cancer is that which has spread just outside the prostate gland, but not to other parts of the body.

Owen Sharp, chief executive of The Prostate Cancer Charity, said: "This is the first research evidence to demonstrate these benefits to men clearly.

"Although we are seeing this treatment combination already being used in practice in some pockets across the country, we now need to urgently see this become more standard clinical practice for the men it would help."


This page was printed from OSL Web site at http://www.osl.uk.com